Aer Traveler
Generic Name: aer traveler
Brand Names:
Aer Traveler Towelette
Astringent
Overview
Astringent
Uses
Temporary relief of anal itching & burning
Dosage
Gently apply to affected areas by patting and then discard
Side Effects
Stop use and ask doctor if rectal bleeding or continued irritation occurs
Interactions
Stop use and ask doctor if rectal bleeding or continued irritation occurs
Warnings
For external use only
Frequently Asked Questions
What is Aer Traveler used for?▼
Temporary relief of anal itching & burning
What are the side effects of Aer Traveler?▼
Stop use and ask doctor if rectal bleeding or continued irritation occurs
What are the important warnings for Aer Traveler?▼
For external use only
Related Medications
Sacubitril/valsartan
sacubitril/valsartan
Dosage form: POWDER. Active ingredients: SACUBITRIL VALSARTAN (1 kg/kg). Category: BULK INGREDIENT.
Bepotastine Besilate Ophthalmic Solution 1.5%
bepotastine besilate ophthalmic solution 1.5%
11 DESCRIPTION Bepotastine besilate ophthalmic solution 1.5% is a sterile, topically administered drug for ophthalmic use. Each mL of bepotastine besilate ophthalmic solution contains 15 mg bepotastine besilate. Bepotastine besilate is designated chemically as (+) -4-[[(S)-p-chloro-alpha -2-pyridylbenzyl]oxy]-1-piperidine butyric acid monobenzenesulfonate. The chemical structure for bepotastine besilate is: Bepotastine besilate is white or pale yellowish crystalline powder.
Omidubicel-onlv
omidubicel-onlv
11 DESCRIPTION OMISIRGE (omidubicel-onlv) is a cryopreserved nicotinamide modified unrelated allogeneic hematopoietic progenitor cell therapy derived from cord blood consisting of 2 cell fractions; a Cultured Fraction (CF) and a Non-cultured Fraction (NF) which are both derived from the same patient-specific cord blood unit (CBU). 1) The CF is a yellowish suspension consisting of allogeneic, hematopoietic CD34+ progenitor cells.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.